PropelRx
PropelRx is a structured fundraising operating system that diagnoses capital readiness, aligns founders with institutional investors, and executes outreach with institutional discipline.
At a Glance
Pricing
3-day diagnostic access — readiness scoring and blurred investor preview. Firm names remain locked.
Engagement
Available On
Listed Mar 2026
About PropelRx
PropelRx is a capital readiness infrastructure platform built for founders who want to raise with institutional discipline. It diagnoses structural readiness across five dimensions — financial, narrative, structural, timing, and reputational — before unlocking signal-enriched investor matching. Over 45 companies are running live capital campaigns inside PropelRx, with access to 2,000+ institutional mandates and 1,300+ active fund profiles across 20+ countries.
- Capital Readiness Scoring — Get a structured readiness score across five institutional dimensions before approaching any investor.
- Signal-Enriched Investor Matching — Matches are unlocked only after structural readiness exceeds a threshold, ensuring alignment on stage, sector, geography, and check size.
- Investor Profile Visibility — Access full investor firm names, partner details, thesis alignment breakdowns, and check size/stage fit scoring.
- Campaign Execution Engine — Automate outreach sequences, track engagement signals, gate your data room, and schedule meetings from a single infrastructure.
- 3-Day Diagnostic Trial — Start with a free 3-day diagnostic to receive readiness scoring and a blurred investor preview before committing to a paid plan.
- Atlas AI Assistant — Chat with Atlas, PropelRx's built-in AI assistant, for immediate support and guidance throughout the fundraising process.
- No Equity Taken — PropelRx operates on a transparent subscription model with an optional success fee (3.95%, capped at $200K) only when capital is secured — no equity required.
- Pro & Enterprise Plans — Dedicated support, multi-raise coordination, and custom solutions available for growth-stage companies via a contact sales process.
Community Discussions
Be the first to start a conversation about PropelRx
Share your experience with PropelRx, ask questions, or help others learn from your insights.
Pricing
3 days
3-day diagnostic access — readiness scoring and blurred investor preview. Firm names remain locked.
- Capital readiness scoring
- Blurred investor preview
- Firm names locked
Institutional Access
Never approach the wrong investor again. See exactly who aligns — firm names, thesis fit, check sizes — before you spend a single hour on outreach.
- Full investor firm names & partners
- Thesis alignment breakdown
- Check size & stage fit scoring
- Sector & geography match data
- Basic outreach activation
- Investor profile visibility
Campaign Execution
Full outreach infrastructure — from first contact to signed term sheet. 3.95% success fee applies only if capital is secured, capped at $200K.
- Everything in Institutional Access
- Automated outreach sequences
- Campaign execution engine
- Engagement & signal tracking
- Data room gating & analytics
- Meeting scheduling infrastructure
Pro & Enterprise
Dedicated support, multi-raise coordination, and custom solutions for growth-stage companies.
- Dedicated support
- Multi-raise coordination
- Custom solutions for growth-stage companies
Capabilities
Key Features
- Capital readiness scoring
- Signal-enriched investor matching
- Investor firm names and partner visibility
- Thesis alignment breakdown
- Check size and stage fit scoring
- Sector and geography match data
- Automated outreach sequences
- Campaign execution engine
- Engagement and signal tracking
- Data room gating and analytics
- Meeting scheduling infrastructure
- 3-day diagnostic free trial
- Atlas AI assistant
- No equity taken
- Success fee model (3.95%, capped at $200K)
